|
"su w c"的相關文件
顯示項目 121-145 / 419 (共17頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-02-02T03:08:13Z |
Factors associated with myocardial infarction after emergency endoscopy for upper gastrointestinal bleeding in high-risk patients: a prospective observational study
|
Lee C.-T.; Huang S.-P.; Cheng T.-Y.; TSUNG-HSIEN CHIANG; Tai C.-M.; Su W.-C.; Huang C.-H.; Lin J.-T.; Wang H.-P. |
| 臺大學術典藏 |
2021-01-28T01:06:46Z |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
|
Chao Y.;Li C.P.;Chao T.Y.;Su W.C.;Hsieh R.K.;Wu M.F.;Kun-Huei Yeh;Kao W.Y.;Chen L.T.;Cheng A.L.; Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; KUN-HUEI YEH; Kao W.Y.; Chen L.T.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:35Z |
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Chao Y.;Hsieh J.-S.;Yeh H.-T.;Su Y.-C.;Wu C.-C.;Chen J.-S.;Tai C.-J.;Bai L.-Y.;Kun-Huei Yeh;Su W.-C.;Li C.-P.; Chao Y.; Hsieh J.-S.; Yeh H.-T.; Su Y.-C.; Wu C.-C.; Chen J.-S.; Tai C.-J.; Bai L.-Y.; KUN-HUEI YEH; Su W.-C.; Li C.-P. |
| 臺大學術典藏 |
2021-01-28T01:06:34Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen Y.-C.;Li C.-P.;Yen C.-J.;Hsu C.;Lin Y.-L.;Lin Z.-Z.;Chen L.-T.;Su W.-C.;Chao Y.;Kun-Huei Yeh;Cheng A.-L.; Shen Y.-C.; Li C.-P.; Yen C.-J.; Hsu C.; Lin Y.-L.; Lin Z.-Z.; Chen L.-T.; Su W.-C.; Chao Y.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:32Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; KUN-HUEI YEH; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-01-15T03:47:38Z |
Veiled right kidney sign in a patient with Valentino's syndrome
|
HSIU-PO WANG; Su W.-C. |
| 臺大學術典藏 |
2021-01-15T03:47:32Z |
Factors associated with myocardial infarction after emergency endoscopy for upper gastrointestinal bleeding in high-risk patients: a prospective observational study
|
Lee C.-T.; Huang S.-P.; Cheng T.-Y.; Chiang T.-H.; Tai C.-M.; Su W.-C.; Huang C.-H.; Lin J.-T.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-15T03:47:19Z |
Tension pneumothorax after an ERCP in a patient with hepatic hydrothorax and sealed-off perforated duodenal ulcer
|
Han M.-L.; Wu Y.-M.; Liu K.-L.; Su W.-C.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-08T03:40:18Z |
Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model
|
Chien L.-H.; Chen C.-H.; Chen T.-Y.; Chang G.-C.; Tsai Y.-H.; Hsiao C.-F.; Chen K.-Y.; Su W.-C.; Wang W.-C.; Huang M.-S.; Chen Y.-M.; Chen C.-Y.; SHENG-KAI LIANG; Chen C.-Y.; Wang C.-L.; Lee M.-H.; Chung R.-H.; Tsai F.-Y.; Hu J.-W.; Katki H.A.; Chatterjee N.; Chanock S.J.; Rothman N.; Lan Q.; Yang P.-C.; Chen C.-J.; Chang I.-S.; Hsiung C.A. |
| 國立成功大學 |
2021 |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Y.-H.;Hung, J.-Y.;Ko, H.-W.;Su, P.-L.;Lai, C.-L.;Chang, H.-C.;Hsia, T.-C.;Lin, S.-H.;Wu, K.-L.;Yang, C.-T.;Su, W.-C.;Chu, Y.-C.;Wang, C.-C.;Liao, W.-Y.;Lin, Y.-T.;Lin, C.-H.;Lin, M.-C.;Hsu, K.-H.;Tseng, J.-S.;Yang, T.-Y.;Chen, K.-C.;Lee, M.-H.;Yu, S.-L.;Ho, C.-C.;Chang, G.-C. |
| 國立成功大學 |
2021 |
Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment
|
Su, P.-L.;Tsai, J.-S.;Yang, S.-C.;Wu, Y.-L.;Tseng, Y.-L.;Chang, Chang C.-C.;Yen, Yen Y.-T.;Lin, C.-Y.;Lin, C.-C.;Wang, C.-C.;Lin, M.-C.;Su, W.-C. |
| 國立成功大學 |
2021 |
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors
|
Shiah, H.-S.;Chiang, N.-J.;Lin, C.-C.;Yen, C.-J.;Tsai, H.-J.;Wu, S.-Y.;Su, W.-C.;Chang, K.-Y.;Wang, C.-C.;Chang, J.-Y.;Chen, L.-T. |
| 國立成功大學 |
2021 |
Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia
|
Blechter, Blechter B.;Wong, J.Y.Y.;Agnes, Hsiung C.;Hosgood, Hosgood H.D.;Yin, Z.;Shu, X.-O.;Zhang, H.;Shi, J.;Song, L.;Song, M.;Zheng, W.;Wang, Z.;Caporaso, N.;Burdette, L.;Yeager, M.;Berndt, S.I.;Teresa, Landi M.;Chen, Chen C.-J.;Chang, G.-C.;Hsiao, C.-F.;Tsai, Y.-H.;Chen, K.-Y.;Huang, M.-S.;Su, W.-C.;Chen, Y.-M.;Chien, L.-H.;Chen, Chen C.-H.;Yang, T.-Y.;Wang, C.-L.;Hung, J.-Y.;Lin, C.-C.;Perng, R.-P.;Chen, Chen C.-Y.;Chen, K.-C.;Li, Y.-J.;Yu, C.-J.;Chen, Y.-S.;Chen, Y.-H.;Tsai, F.-Y.;Jie, Seow W.;Bassig, Bassig B.A.;Hu, W.;Ji, B.-T.;Wu, Wu W.;Guan, P.;He, Q.;Gao, Y.-T.;Cai, Q.;Chow, W.-H.;Xiang, Y.-B.;Lin, D.;Wu, C.;Wu, Y.-L.;Shin, M.-H.;Hong, Y.-C.;Matsuo, K.;Chen, K.;Pik, Wong M.;Lu, D.;Jin, L.;Wang, J.-C.;Seow, A.;Wu, T.;Shen, H.;Fraumeni, J.F.;Yang, P.-C.;Chang, I.-S.;Zhou, B.;Chanock, S.J.;Rothman, N.;Chatterjee, N.;Lan, Q. |
| 國立成功大學 |
2021 |
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing
|
Lin, Y.-T.;Chiang, Chiang C.-L.;Hung, J.-Y.;Lee, M.-H.;Su, W.-C.;Wu, S.-Y.;Wei, Y.-F.;Lee, K.-Y.;Tseng, Y.-H.;Su, J.;Chung, H.-P.;Lin, C.-B.;Ku, W.-H.;Chiang, T.-S.;Chiu, Chiu C.-H.;Shih, J.-Y. |
| 國立成功大學 |
2021 |
Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer
|
Yang, S.-C.;Kunst, N.;Gross, C.P.;Wang, J.-D.;Su, W.-C.;Wang, S.-Y. |
| 國立成功大學 |
2021 |
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
|
Park, K.;Tan, D.S.W.;Su, W.-C.;Cho, B.C.;Kim, S.-W.;Lee, K.H.;Wang, C.-C.;Seto, T.;Huang, D.C.-L.;Jung, H.H.;Hsu, M.-C.;Bogenrieder, T.;Lin, C.-C. |
| 國立成功大學 |
2021 |
Durable Response to Combined Dabrafenib and Trametinib in a Patient With BRAF K601E Mutation-Positive Lung Adenocarcinoma: A Case Report
|
Su, P.-L.;Lin, C.-Y.;Chen, Y.-L.;Chen, W.-L.;Lin, C.-C.;Su, W.-C. |
| 國立成功大學 |
2021 |
Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study
|
Yang, J.C.-H.;Reckamp, K.L.;Kim, Y.-C.;Novello, S.;Smit, E.F.;Lee, J.-S.;Su, W.-C.;Akerley, W.L.;Blakely, C.M.;Groen, H.J.M.;Bazhenova, L.;Carcereny, Costa E.;Chiari, R.;Hsia, T.-C.;Golsorkhi, T.;Despain, Despain D.;Shih, D.;Popat, S.;Wakelee, H. |
| 國立成功大學 |
2021 |
Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers
|
Liang, S.-K.;Chien, L.-H.;Chang, G.-C.;Tsai, Y.-H.;Su, W.-C.;Chen, Y.-M.;Huang, M.-S.;Lin, H.-C.;Fang, W.-T.;Hung, Hung H.-H.;Jiang, S.-S.;Chen, Chen C.-Y.;Chen, K.-Y.;Chang, I.-S.;Hsiung, C.A.;Chen, Chen C.-J.;Yang, P.-C.;Group, the GELAC Study |
| 國立成功大學 |
2021 |
Degradation Behavior of Etch-Stopper-Layer Structured a-InGaZnO Thin-Film Transistors under Hot-Carrier Stress and Illumination
|
Lin, D.;Su, W.-C.;Chang, T.-C.;Chen, H.-C.;Tu, Y.-F.;Zhou, K.-J.;Hung, Y.-H.;Yang, J.;Lu, I.-N.;Tsai, Tsai T.-M.;Zhang, Q. |
| 國立成功大學 |
2021 |
Safety and Antitumor Activity of a-PD-L1 Antibody as Monotherapy or in Combination witha-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors
|
Hollebecque, A.;Chung, H.C.;Miguel, Miguel M.J.D.;Italiano, A.;MacHiels, J.-P.;Lin, C.-C.;Dhani, N.C.;Peeters, M.;Moreno, V.;Su, W.-C.;Chow, K.H.;Galvao, V.R.;Carlse, M.;Yu, D.;Szpurka, A.M.;Zhao, Y.;Schmidt, Schmidt S.L.;Gandhi, L.;Xu, Xu X.;Bang, Y.-J. |
| 國立成功大學 |
2021 |
Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC
|
Herbst, R.S.;Garon, E.B.;Kim, D.-W.;Cho, B.C.;Gervais, R.;Perez-Gracia, J.L.;Han, J.-Y.;Majem, Majem M.;Forster, M.D.;Monnet, I.;Novello, S.;Gubens, M.A.;Boyer, M.;Su, W.-C.;Samkari, A.;Jensen, E.H.;Kobie, J.;Piperdi, B.;Baas, P. |
| 國立成功大學 |
2021 |
Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: The PACT phase Ia/Ib trial
|
Patnaik, A.;Yap, T.A.;Chung, H.C.;de, Miguel M.J.;Bang, Y.-J.;Lin, C.-C.;Su, W.-C.;Italiano, A.;Chow, K.H.;Szpurka, A.M.;Yu, D.;Zhao, Y.;Carlsen, M.;Schmidt, Schmidt S.;Vangerow, B.;Gandhi, L.;Xu, Xu X.;Bendell, J. |
| 國立成功大學 |
2021 |
Overcoming radiation resistance by iron-platinum metal alloy nanoparticles in human copper transport 1-overexpressing cancer cells via mitochondrial disturbance
|
Tsai, Tsai T.-L.;Lai, Y.-H.;Chen, H.H.W.;Su, W.-C. |
| 臺大學術典藏 |
2020-12-25T07:43:46Z |
Gastrointestinal: Bleeding gastric diverticulum
|
Chen J.-H.; Su W.-C.; Chang C.-Y.; HUNG-JU LIN |
顯示項目 121-145 / 419 (共17頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
